Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Altimmune, Inc.

TRADE

NASDAQ: ALTHealthcare / Biotechnology / -
3.31-0.09-2.65%Vol 551 0081Y Perf -94.92%
Nov 14th, 2018 14:00
BID3.30 ASK3.31
Open3.40 Previous Close3.40
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.00 
Analyst Rating
Strong Buy 1.00
Potencial %
202.12 
Finscreener Ranking
★★★★+     59.08
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
★★★★     56.61
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★     45.52
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)6 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
0.65 
Earnings Date
15th Nov 2018

Today's Price Range

2.903.53

 

52wk Range

2.9066.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-18.27%
3 Months
-68.52%
6 Months
-78.21%
1 Year
-94.92%
3 Years
-94.39%
5 Years
-95.21%

Quotes

Name / TickerPriceChg.Chg.%
ALT3.31-0.0900-2.65
AAPL186.47-5.7600-3.00
GOOG1 038.502.45000.24
MSFT104.77-2.1700-2.03
XOM76.97-1.0300-1.32
WFC51.75-0.9900-1.88
JNJ144.01-0.6700-0.46
FB142.920.76000.53
GE8.23-0.3800-4.41
JPM106.15-3.4400-3.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.50
Current Ratio 1.70
Long Term Debt to Total Capital 0.02
Total Debt to Equity 0.05
Interest Coverage -8 112.50
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-465.10
EBITDA Margin-463.60
Pre-tax Profit Margin648.20
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 0.00
PB Ratio 0.43
PS Ratios 1.93
Price to Cash Flow 0.10
Price to Free Cash Flow -1.70
Cash Flow Per Share -18.24
Price to Tangible Book-6.02
Book Value per Share8.69
Enterprise Value (in ths.)13 011
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)117.83
ROE last 12 Months -104.50
Return on Assets (5Y Avg) 32.97
ROA last 12 Months -81.72
Return on Capital (5Y Avg) 145.00
ROC last 12 Months -102.34
Return on invested Capital Q -24.99
Return on invested Capital Y-170.41
Assets Turnover0.10
Receivables Turnover0.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)7 917
Revenue per Share 1.92
Revenue Growth 3 Years -4.75
Revenue Growth 5 Years -14.65
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-3.60-1.7351.94
Q02 2018-4.50-4.80-6.67
Q01 2018-15.02-6.9153.99
Q04 2017-15.02-3.6076.03
Q03 2017-6.91-10.21-47.76
Q04 2016-11.80-
Q02 2016-1.20-
Q01 2016--0.02-
Earnings Per EndEstimateRevision %Trend
9/2018 QR-3.6033.46Positive
12/2018 QR-2.8037.78Positive
12/2018 FY-21.87-1.16Negative
12/2019 FY-2.060.00-
Next Report Date15th Nov 2018
Estimated EPS Next Report-3.60
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume551 008
Shares Outstanding (in ths.)1 720
Trades Count1 227
Dollar Volume1 692 224
Avg. Volume304 830
Avg. Weekly Volume449 685
Avg. Monthly Volume530 551
Avg. Quarterly Volume982 730

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

41%59%

Bearish Bullish

42%58%

Bearish Bullish

29%71%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x